[go: up one dir, main page]

Nickerson et al., 1953 - Google Patents

Blockade of responses to epinephrine and norepinephrine by dibenamine congeners

Nickerson et al., 1953

View PDF
Document ID
1281563038967841403
Author
Nickerson M
Henry J
Nomaguchi G
Publication year
Publication venue
The Journal of Pharmacology and Experimental Therapeutics

External Links

Snippet

The ability of β-haloalkylamine adrenergic blocking agents to inhibit excitatory responses to epinephrine and norepinephrine has been studied in cats. The chronically denervated nictitating membrane and the intact vascular system during maximum stimulation of the …
Continue reading at citeseerx.ist.psu.edu (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/417—Imidazole-alkylamines, e.g. histamine, phentolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epihephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N-C(O)-N< or >N-C(S)-N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group

Similar Documents

Publication Publication Date Title
Nickerson et al. Blockade of responses to epinephrine and norepinephrine by dibenamine congeners
Talley et al. Evaluation of the pre-ejection period as an estimate of myocardial contractility in dogs
Griesemer et al. Potentiating effect of iproniazid on the pharmacological action of sympathomimetic amines.
Vanhoutte Inhibition by acetylcholine of adrenergic neurotransmission in vascular smooth muscle
Reid et al. Cardiovascular effects of intracerebroventricular d-, l-and dl-propranolol in the conscious rabbit
DOYLE et al. Reactivity to pressor agents in hypertension
Briggs et al. Neurophysiology and pharmacology of long‐term potentiation in the rat sympathetic ganglion.
Duckles et al. Vascular adrenergic neuroeffector function does not decline in aged rats.
Knuepfer et al. Cardiovascular responses to cocaine are initially mediated by the central nervous system in rats.
Barron et al. Role of sympathoadrenomedullary system in cardiovascular response to stress in rats
Watanabe et al. Effect of L‐dopa alone and in combination with an extracerebral decarboxylase inhibitor on blood pressure and some cardiovascular reflexes
Foreman et al. Field potentials and excitation of primate spinothalamic neurones in response to volleys in muscle afferents.
Bell Mechanism of enhancement by angiotensin II of sympathetic adrenergic transmission in the guinea pig
Watanabe et al. Effect of L-dopa on blood pressure and sympathetic nerve activity after decarboxylase inhibition in cats
Richards et al. Circulatory and alpha‐adrenoceptor blocking effects of phentolamine.
Engberg et al. The effect of reserpine on transmission in the spinal cord
Fink et al. The area postrema in deoxycorticosterone-salt hypertension in rats.
Gardier et al. Specific blockade of the adrenal medulla
Drop et al. Anesthesia for electroconvulsive therapy in patients with major cardiovascular risk factors
Mark et al. Renal vascular responses to isoproterenol
US5513661A (en) Use of sympathetic blockade for treatment of chronic muscle pain
Ciofalo et al. Some aspects of the anti-arrhythmic activity of reserpine
Gilmore et al. The effect of l-norepinephrine on cardiac output in the anesthetized dog during graded hemorrhage
Koos et al. Nimodipine treatment of ischemic neurological deficits due to cerebral vasospasm after subarachnoid hemorrhage: clinical results of a multicenter study
Rechtman et al. A facilitatory effect of anti‐angiotensin drugs on vagal bradycardia in the pithed rat and guinea‐pig